A test with pregnant
women.
"To our knowledge,
the only product to
go through an 18
month NHS
commissioned and
managed study with
pregnant women."
Analysing the
figures
Although hopes were
high, expectations
at the start of thee
study were not
great, after all
anecdotal testimony
from mothers was all
we had.
Despite there being
a broad pattern to
the results there
were instances that
did not meet logic.
Why did some mothers
with very mild
symptoms fail to
gain benefit, when
some mothers with
Hyperemesis
Gravidarum derived
the greatest
benefit?
Efficacy and
analysis
The mood swing in
the study now
centres on why did
it not work for the
ten percent? Is
there something we
missed or that the
mother is doing that
brought about the
failure to stop the
symptoms? Already we
have seen three
revisions in the
simple and concise
instructions for use
that improved the
success ratio during
the study.